EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High‐Volume Sarcoma Centre

Abdeali Saif Arif Kaderi iD, Tanvi M Shah iD, Shraddha Patkar iD, Y Aditya Sai Ram, Vinayaka S Bairannavar, M Myvizhi Kannan, Bharat Rekhi iD, Prabhat Bhargav iD, Kunal B Gala iD, Afroj Bagwan iD, Mukta Ramadwar, Jifmi Jose und 3 weitere

Journal of Surgical Oncology · 2026-07 · 134 (1) · 116-127

DOI: 10.1002/jso.70264 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 06.05.2026. Verfasst von Abdeali Saif Arif Kaderi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Retroperitoneal Neoplasms, Neoplasm Recurrence, Local, Sarcoma. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Retroperitoneal sarcoma (RPS) is a rare and complex malignancy, requiring specialized multidisciplinary care. While a significant progress has been made in managing a primary RPS, there is a limited literature on the outcomes of recurrent RPS (RecRPS). This study evaluates the oncological outcomes of RecRPS at a leading sarcoma referral center in India.

Methods

A retrospective analysis was performed for patients with RecRPS who underwent surgery between January 2011 and December 2024. Clinical outcomes were analyzed using Kaplan‐Meier method and compared using log‐rank test. Extended Cox regression models were used to account for intra‐individual correlation, in cases of multiple recurrence. Prentice, William and Peterson model (PWP) CP model (total time) and PWP Gap time (PWP‐GT) models were employed to estimate predictors of multiple recurrences.

Results

Out of 285 patients with primary RPS, 160 (56.1%) underwent surgery for a recurrent disease. The median overall survival (OS) was 137.1 months for the entire cohort and 41.92 months in RecRPS. The median OS of patients with 1st recurrence was 38.97 months. For subsequent recurrences, the median OS were 74.94 months (2nd recurrence), 57.4 months (3rd recurrence) and 54.2 months (4th recurrence), respectively. The various clinicopathological parameter associated with multiple recurrences were R+resection or resection with unknown margins, dedifferentiated liposarcoma and leiomyosarcoma, as histopatholologic subtypes; histologic organ invasion (HOI) of the small bowel and vessels, requirement of adjuvant and neoadjuvant therapy, disease progression on neoadjuvant chemotherapy and grade IIIb and IV complications.

Conclusion

While the best chance of cure is at the primary presentation, some patients may experience prolonged disease control even with multiple recurrence, if treated optimally.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retroperitoneal NeoplasmsNeoplasm Recurrence, LocalSarcomaHumansRetrospective StudiesMaleFemaleMiddle AgedSurvival RateAdultHospitals, High-VolumeAgedFollow-Up Studies

Stichwörter der Autor:innen

compartmental resectionsmultiple recurrencesrecurrent retroperitoneal sarcomasretroperitoneal sarcomas

Autor:innen und Institutionen

  • Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Division of Hepaobiliary, Gastrointestinal and Retroperitoneal Sarcoma surgery, Department of Surgical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Department of Interventional Radiology, ACTREC, Homi Bhabha National Institute, Mumbai, Maharashtra, India.
  • Department of Radiotherapy, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India.

ORCID-Profile: Abdeali Saif Arif Kaderi, Tanvi M Shah, Shraddha Patkar, Bharat Rekhi, Prabhat Bhargav, Kunal B Gala, Afroj Bagwan, Mahesh Goel

Zitieren

APA

Kaderi, A. S. A., Shah, T. M., Patkar, S., Sai Ram, Y. A., Bairannavar, V. S., Myvizhi Kannan, M., Rekhi, B., Bhargav, P., Gala, K. B., Bagwan, A., Ramadwar, M., Jose, J., Khanna, N., Laskar, S., & Goel, M. (2026). Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High‐Volume Sarcoma Centre. Journal of Surgical Oncology, 134(1), 116-127. https://doi.org/10.1002/jso.70264

Vancouver

Kaderi ASA, Shah TM, Patkar S, Sai Ram YA, Bairannavar VS, Myvizhi Kannan M, et al. Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High‐Volume Sarcoma Centre. Journal of Surgical Oncology. 2026;134(1):116-127. doi:10.1002/jso.70264

BibTeX
@article{Kaderi2026,
  author = {Kaderi, Abdeali Saif Arif and Shah, Tanvi M and Patkar, Shraddha and Sai Ram, Y Aditya and Bairannavar, Vinayaka S and Myvizhi Kannan, M and Rekhi, Bharat and Bhargav, Prabhat and Gala, Kunal B and Bagwan, Afroj and Ramadwar, Mukta and Jose, Jifmi and Khanna, Nehal and Laskar, Siddhartha and Goel, Mahesh},
  title = {Surgical Management of Recurrent Retroperitoneal Sarcomas: Experience From a High‐Volume Sarcoma Centre},
  journal = {Journal of Surgical Oncology},
  year = {2026},
  volume = {134},
  number = {1},
  pages = {116--127},
  doi = {10.1002/jso.70264}
}
Kostenlos starten →